ESC 365 - PTX3 as a novel inflammatory biomarker in patients with myocarditis

ESC Professional Premium Access

PTX3 as a novel inflammatory biomarker in patients with myocarditis

Session: Pericardial disease, myocardial disease, COVID-19

Topic: Diagnostic Methods

Speaker: Doctor A. Villatore (Milan, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Andrea Villatore

IRCCS San Raffaele Scientific Institute, Milan (Italy)

1 follower

5 more presentations in this session

Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals

Speaker: Mr M. Lassen (Boston, US)

Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants

Speaker: Doctor E. Kulikowski (Calgary, CA)

No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers

Speaker: Doctor M. Radvan (Brno, CZ)

Clinical outcome of patients with severe malignant pericardial effusion due to neoplastic disease undergoing percutaneous balloon pericardiotomy during COVID-19 pandemic

Speaker: Doctor E. Alfonso Rodriguez (Hospitalet de Llobregat, ES)

The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank

Speaker: Doctor P. Welsh (Glasgow, GB)

Access the full session

Pericardial disease, myocardial disease, COVID-19

Speakers: Doctor A. Villatore, Mr M. Lassen, Doctor E. Kulikowski, Doctor M. Radvan, Doctor E. Alfonso Rodriguez...

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources